Oregon 2022 Regular Session

Oregon House Bill HB4042

Introduced
2/1/22  
Refer
2/1/22  

Caption

Relating to abortion; prescribing an effective date.

Impact

The legislation aims to address public concerns around abortion and its accessibility. By informing patients about the potential for reversal, supporters argue that it empowers women to make more informed decisions. However, this requirement could impose an additional layer of obligation on healthcare providers, which may lead to apprehension regarding compliance and the potential for legal consequences. Furthermore, the bill allows for individuals to sue healthcare providers for both actual and punitive damages if they believe the abortion was improperly performed or induced without adequate information regarding reversal options.

Summary

House Bill 4042 introduces new regulations concerning chemical abortions in Oregon. The bill mandates that any physician prescribing drugs for chemical abortions, specifically mifepristone and misoprostol, must inform the patient at least 24 hours in advance about the possibility of reversing the abortion process. Additionally, the Oregon Health Authority is required to maintain a website that provides information about the abortion reversal process and resources available to assist individuals wishing to reverse their decision. This includes the provision of a hotline for immediate contact regarding reversal options.

Contention

The bill is likely to draw significant debate reflecting broader societal divisions over abortion. Proponents may view it as a necessary measure to safeguard women's health and promote informed consent, while opponents may see it as an infringement on medical practice and an attempt to undermine women's autonomy. Concerns have also been raised about the accuracy of information regarding chemical abortion reversals and the implications of potential lawsuits against providers. Thus, HB 4042 positions itself at the intersection of medical ethics, legality, and personal rights.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.